EysterM. Home therapy program. In: HilgartnerM ed. Hemophilia in the child and adult. New York: Masson Publishing Company,1982: 219–31.
2.
GillFM. The natural history of Factor VIII inhibitors in patients with hemophilia A. In: HoyerL ed. Factor VIII inhibitors. New York: Alan R. Liss,1984: 19–29.
3.
GreenDLechnerK. A survey of 215 nonhemophilic patients with inhibitors to Factor VIII.Thromb Haemost1981; 45: 2003.
4.
BlattPMWhiteGCIIMcMillanWWebsterWP. Failure of activated prothrombin-complex concentrates in hemophiliacs with an anti-Factor VIII antibody.JAMA1984; 251: 67.
5.
LusherJMShapiroSSPalascakJE. Efficacy of prothrombin-complex concentrates in hemophiliacs with antibodies to Factor VIII.N Engl J Med1980; 303: 4215.
6.
AbildgaardCPennerJAWatson-WilliamsEJ. Anti-inhibitor coagulant complex (Autoplex) for treatment of Factor VIII inhibitors in hemophilia.Blood1980; 56: 97884.
7.
ColvinBT. Role of plasma exchange in the management of patients with Factor VIII inhibitors.Ric Clin Lab (Milano)1983; 13: 8593.
8.
NilssonIMJohnsonSSundquistS-BAhlbertABergentzS-E. A procedure for removing high titer antibodies by extra corporeal protein-A-sepharase absorption in hemophilia: substitution therapy and surgery in a patient with hemophilia B and antibodies.Blood1981; 58: 3844.
9.
PennerJHasounaH. Inhibitor disorders with comments on management. Proceedings of the Second International Symposium on Hemophilia Treatment. Tokyo,1981.
10.
SjamsaedinLHeijnenLMaujer-BunschotenE. The effect of activated prothrombin complex concentrate (FEIBA) on joint and muscle bleeding in patients with hemophilia A and antibodies to Factor VIII.N Engl J Med1981; 305: 71721.
11.
LusherJ. Hemophilia and related disorders. In: EdlichRFSipkerD eds. Current emergency therapy. Los Altos, Calif.: Appleton and Lange Publishing Company,1984: 519–29.
12.
WhiteGCIIRobertsHKingdonHLundbladR. Prothrombin complex concentrates: potentially thrombogenic materials and clues to the mechanism of thrombosis in vivo.Blood1977; 40: 15970.